Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -11.04 % |
3 Month Return | + 2.95 % |
1 Year Return | + 24.73 % |
Market Stats | |
Previous Close | ₹414.05 |
Open | ₹414.05 |
Volume | 69.05K |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹4,151.99Cr |
P/E Ratio | 48.83 |
PEG Ratio | 12.33 |
Market Cap | ₹4,151.99 Cr |
P/B Ratio | 0 |
EPS | 0 |
Dividend Yield | 0.04 |
Sector | Pharmaceuticals |
ROE | 19.57 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹4,151.99 Cr | 101.24% | 0.70 | ₹86 Cr | ₹806 Cr | |
NA | ₹633.91 Cr | 412.17% | 0.54 | ₹23 Cr | ₹164 Cr | |
NA | ₹146.51 Cr | 49.47% | 0.57 | NA | NA | |
NA | ₹1,048.70 Cr | 112.94% | 0.53 | ₹50 Cr | ₹614 Cr | |
NA | ₹113.17 Cr | 10.94% | 0.57 | NA | NA |
Organisation | Gufic BioSciences Ltd |
Headquarters | Mumbai |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Gufic BioSciences Ltd
Gufic Biosciences Reports Decline in Q2 Profit - 18 Nov, 2024
Gufic Biosciences Reports Decline in Q2 Profit - 15 Nov, 2024
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
MF Holding Up
Mutual Funds have increased holdings from 2.30% to 2.51% in Sep 2024 quarter
FII Holding Up
Foreign Institutions have increased holdings from 0.23% to 0.24% in Sep 2024 quarter
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 62.5% return, outperforming this stock by 37.8%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 72.51% of holdings in Sep 2024 quarter
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 132.4% return, outperforming this stock by 16.4%
Price Dip
In the last 1 month, GUFICBIO stock has moved down by -11.0%
Retail Holding Down
Retail Investor have decreased holdings from 24.88% to 24.74% in Sep 2024 quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 72.51% | 0.00 | |
Foreign Institutions | 0.24% | 2.75 | |
Mutual Funds | 2.51% | 9.23 | |
Retail Investors | 24.74% | ||
Others | 0% |
Gufic BioSciences Ltd in the last 5 years
Lowest (0.00x)
March 28, 2024
Today (48.83x)
November 29, 2024
Industry (55.31x)
November 29, 2024
Highest (57.25x)
November 8, 2024
Gufic BioSciences Ltd’s net profit fell -6.2% since last year same period to ₹21.77Cr in the Q2 2024-2025. On a quarterly growth basis, Gufic BioSciences Ltd has generated 4.36% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2024, Gufic BioSciences Ltd has declared dividend of ₹0.10 - translating a dividend yield of 0.05%.
Read More about DividendsBearish
Neutral
Bullish
Gufic BioSciences Ltd is currently in a Bearish trading position according to technical analysis indicators.
Gufic BioSciences Ltd (GUFICBIO) share price today is ₹410.7
Gufic BioSciences Ltd is listed on NSE
Gufic BioSciences Ltd is listed on BSE
PE Ratio of Gufic BioSciences Ltd is 48.83
PE ratio = Gufic BioSciences Ltd Market price per share / Gufic BioSciences Ltd Earnings per share
Today’s traded volume of Gufic BioSciences Ltd(GUFICBIO) is 69.05K.
Today’s market capitalisation of Gufic BioSciences Ltd(GUFICBIO) is ₹4151.99Cr.
Gufic BioSciences Ltd(GUFICBIO | Price |
---|---|
52 Week High | ₹504.25 |
52 Week Low | ₹277.65 |
Gufic BioSciences Ltd(GUFICBIO) share price is ₹410.7. It is down -18.55% from its 52 Week High price of ₹504.25
Gufic BioSciences Ltd(GUFICBIO) share price is ₹410.7. It is up 47.92% from its 52 Week Low price of ₹277.65
Gufic BioSciences Ltd(GUFICBIO | Returns |
---|---|
1 Day Returns | -3.35% |
1 Month Returns | -11.04% |
3 Month Returns | 2.95% |
1 Year Returns | 24.73% |